Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan. - Suppr | 超能文献

Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan.

作者信息

Minaguchi H, Uemura T, Shirasu K

出版信息

Prog Clin Biol Res. 1986;225:211-25.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan.

Prog Clin Biol Res. 1986;225:211-25.

2

Efficacy of different modalities of LHRH agonist (buserelin) administration on the inhibition of the pituitary-ovarian axis for the treatment of endometriosis.

Prog Clin Biol Res. 1986;225:157-73.

3

The effect of LHRH agonist therapy in the treatment of endometriosis (Dutch experience).促黄体生成素释放激素激动剂疗法治疗子宫内膜异位症的效果（荷兰的经验）

Prog Clin Biol Res. 1986;225:201-10.

4

Effect of LH-RH agonist therapy in the treatment of endometriosis (German experience).促性腺激素释放激素激动剂疗法在子宫内膜异位症治疗中的作用（德国经验）。

Prog Clin Biol Res. 1986;225:189-99.

5

A preliminary report on the comparative use of buserelin (Hoe 766) and danazol in the treatment of endometriosis: the University of Southern California experience.布舍瑞林（Hoe 766）与达那唑治疗子宫内膜异位症的对比应用初步报告：南加州大学的经验

Prog Clin Biol Res. 1986;225:175-88.

6

CA-125 monitored therapy with GnRH analogue of pelvic endometriosis.

Acta Eur Fertil. 1992 Jul-Aug;23(4):171-4.

7

Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens.

Clin Reprod Fertil. 1986 Oct;4(5):329-36.

8

[Treatment of endometriosis with the GnRH agonist buserelin (Suprecur): a multicenter study].

Geburtshilfe Frauenheilkd. 1994 Oct;54(10):569-73. doi: 10.1055/s-2007-1022341.

9

[Androgens and other hormones in buserelin therapy].

Geburtshilfe Frauenheilkd. 1991 Feb;51(2):140-2. doi: 10.1055/s-2007-1023690.

10

Effect of LHRH agonist (buserelin) on pulsatile secretion of LHRH and LH.

Nihon Sanka Fujinka Gakkai Zasshi. 1988 Dec;40(12):1889-93.

引用本文的文献

1

Gonadotropin-releasing hormone analogues for endometriosis.促性腺激素释放激素类似物治疗子宫内膜异位症。

Cochrane Database Syst Rev. 2023 Jun 21;6(6):CD014788. doi: 10.1002/14651858.CD014788.pub2.

2

Current and Emerging Therapeutics for the Management of Endometriosis.当前和新兴的子宫内膜异位症治疗方法。

Drugs. 2018 Jul;78(10):995-1012. doi: 10.1007/s40265-018-0928-0.

3

Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.用于治疗子宫内膜异位症相关疼痛的促性腺激素释放激素类似物

Cochrane Database Syst Rev. 2010 Dec 8;2010(12):CD008475. doi: 10.1002/14651858.CD008475.pub2.

4

Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.布舍瑞林。对其药效学和药代动力学特性以及临床概况的综述。

Drugs. 1990 Mar;39(3):399-437. doi: 10.2165/00003495-199039030-00007.